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Abstract HSV-2 R1, the R1 subunit of herpes simplex virus
(HSV) ribonucleotide reductase, protects cells against apopto-
sis. Here, we report the presence in HSV-2 R1 of a stretch
exhibiting similarity to the K-crystallin domain of the small
heat shock proteins, a domain known to be important for oligo-
merization and cytoprotective activities of these proteins. Also,
the HSV-2 R1 protein, which forms multimeric structures in the
absence of nucleotide, displayed chaperone ability as good as
Hsp27 in a thermal denaturation assay using citrate synthase.
In contrast, mammalian R1, which does not contain an K-crys-
tallin domain, has neither chaperone nor anti-apoptotic activity.
Thus, we propose that the chaperone activity of HSV-2 R1
could play an important role in viral pathogenesis.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The herpes simplex virus type 1 and 2 (HSV-1, -2) ribonu-
cleotide reductase (RR), which converts ribonucleoside di-
phosphates to the corresponding deoxyribonucleotides, plays
a key role in the synthesis of viral DNA in resting cells (re-
viewed in [1]). The association of two subunits, denoted R1
and R2, the former of which contains the active site, forms the
holoenzyme. Based on studies of Escherichia coli RR, the
HSV holoenzyme is typically depicted as an R12R22 hetero-
tetramer. The HSV RRs di¡er from their mammalian homo-
logues by being produced in excess over their requirement for
viral DNA synthesis (N. Lamarche and Y. Langelier, unpub-
lished results) and by being unresponsive to allosteric nucleo-
tide e¡ectors [1]. Moreover, whereas mammalian R1 is mono-
meric in the absence of added ligands [2^4], HSV R1 like
E. coli R1 [5] is believed to be dimeric. For E. coli R1, two
K-helices located in the ¢rst third of the protein provide es-
sential contacts for dimerization [6].
Two observations suggest that the HSV R1s could be pro-
teins with more than one function: (i) they possess a unique
NH2 domain of V400 amino acids that is dispensable for
ribonucleotide reduction [7], and (ii) their synthesis begins
before that of their R2 partners [8]. The long-standing view
that their unique NH2 domain could possess an intrinsic pro-
tein kinase activity [9^12] was ruled out by the demonstration
that both HSV-1 R1 and HSV-2 R1 do not possess such an
activity [13,14]. We previously found that the HSV-2 R1 pro-
tects the cells from death receptor-induced apoptosis, suggest-
ing that it could contribute to viral propagation by preventing
apoptosis induced by the immune system. The R1 NH2 do-
main expressed on its own does not exhibit anti-apoptotic
activity, suggesting that both domains of R1 or part(s) of
them are necessary for this new function [15].
The reports of homology between HSV-2 R1 and the small
heat shock protein (sHsp) HspB8 [16,17] led us to observe in
HSV R1 a stretch exhibiting similarity to the K-crystallin do-
main of sHsps. In these proteins, the C-terminal K-crystallin
domain is £anked by a short £exible tail and by a variable
N-terminal domain. The 3D structures of Hsp16.5 from Me-
thanococcus jannaschii and of Hsp16.9 from wheat show that,
despite a low level of identity (V20%), the K-crystallin do-
mains of these evolutionarily distantly related proteins adopt
a similar immunoglobulin G-like fold [18,19]. A group of 25
proteins of the Arabidopsis genome were reported to contain
one or more K-crystallin domains at variable positions in their
polypeptide chains [20]. The K-crystallin domain acts as a
£exible structural building block for the formation by sHsps
of high molecular mass structures. sHsps exhibit the in vitro
ability to bind unfolded proteins and to prevent their aggre-
gation in an ATP-independent manner (reviewed in [21]). Re-
cent genetic data demonstrated a correlation between sHsp
function in vivo and chaperone activity in vitro [22]. Also,
the chaperone as well as other more speci¢c activities of sev-
eral sHsps are likely responsible for their cytoprotective and
anti-apoptotic activity against several cytotoxic treatments in-
cluding activation of the death receptors [23,24].
It was recently found that the K-crystallin domain and the
cochaperone of Hsp90, p23, which has the same 3D folding as
the K-crystallin domain, show a pattern of conserved residues
suggesting a common evolutionary origin for both domains.
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p23-like domains were detected in several families of proteins
fused with other domains in several multidomain proteins
[25].
Here, we show that the anti-apoptotic HSV-2 R1 with its
K-crystallin domain forms a hexameric structure in the ab-
sence of nucleotide and has a chaperone activity as potent
as Hsp27. Devoid of such a domain, the mammalian R1
does not have chaperone activity and does not protect cells
from apoptosis induced by death receptor activation.
2. Materials and methods
2.1. Materials
The conditions for the culture of human HeLa and A549-tTA cells
were as reported [26]. The plasmids, pAdCMV5-HSV-2 R1 for the
expression of the HSV-2 R1 and pAdCMV5-GFP for the expression
of a mutated green £uorescent protein, have been described [26,27].
Plasmid pAdCMV5-HuR1 for the expression of the human R1
(HuR1) was constructed by inserting in pAdCMV5 the HuR1 coding
sequence taken from plasmid pJVETLZ-HuR1. Recombinant HSV-2
R1 was puri¢ed by peptide a⁄nity as described [13]. Recombinant
mouse R1 (mR1), puri¢ed by peptide a⁄nity [28], was kindly pro-
vided by Barry Cooperman. Recombinant Chinese hamster Hsp27
and v5^23Hsp27, a chaperone inactive mutant of Hsp27 (H. Lambert
and J. Landry, unpublished results), were obtained from glutathione
S-transferase^Hsp27 fusion proteins. The fusion proteins were a⁄nity
puri¢ed on glutathione-Sepharose beads, treated with thrombin to
release the Hsp27 proteins and further puri¢ed to homogeneity by
anion exchange chromatography [29].
2.2. Gel ¢ltration
For the experiment with 0.7 WM HSV-2 R1, the puri¢ed protein
was slightly labeled with [Q-32P]ATP taking advantage of traces of
contaminating protein kinase(s) as described [13]. Samples (100 Wl)
were loaded on a Superdex 200 hr10/10 column with 50 mM HEPES
(pH 7.9), 2 mM dithiothreitol containing either 150 mM NaCl (stan-
dard bu¡er) or 1 M NaCl at a £ow rate of 0.5 ml/min. The radio-
activity was measured by Cerenkov counting. Blue dextran (2000
kDa), thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232
kDa), aldolase, (158 kDa) and bovine serum albumin (65 kDa) were
used as molecular mass standards.
2.3. Chaperone activity
The kinetics of thermal denaturation of citrate synthase (CS) were
measured using a Varian spectrophotometer (model Cary 1 Bio)
equipped with a temperature-controlled cell holder. CS was diluted
to 75 nM (dimer) in 50 mM HEPES (pH 7.5) in the absence or
presence of Hsp27, HSV-2 R1 or mR1. Light scattering was measured
at 320 nm at 43‡C.
Fig. 1. HSV R1s exhibit similarity to the K-crystallin domain of sHsps. A: Alignment of the K-crystallin domains of the two HSV R1s, nine of
the known human sHsps, wheat Hsp16.9 and M. jannaschii Hsp16.5. Residues conserved in at least six of the 13 sequences are in black. The
bottom lines show the L-strands present in the secondary structures of TaHsp16.9 and MjHsp16.5, respectively [18,19]. The human sHsps are
here designated ‘HspB 1^9’ as proposed by Kappe¤ et al. [17] and by their corresponding old nomenclature. B: Schematic representation of the
domains present in HSV R1s, HuR1 and Hsp27. For HSV R1s, regions exhibiting s 70% similarity between the two HSV types are depicted
by dark gray boxes and 6 50% by hatched boxes. The reductase domain contains two sub-domains termed all alpha domain (Pfam, ribonu-
c_red_lg) and barrel domain (Pfam, ribonuc_red_lgC). The K-crystallin domain shown in black is absent in HuR1 where the amino-terminal
part forms a nucleotide binding site. The WDPF domain in Hsp27 is responsible for intermolecular Hsp27 interactions [29] and essential for
chaperone activity (H. Lambert and J. Landry, unpublished results).
FEBS 27341 3-6-03
S. Chabaud et al./FEBS Letters 545 (2003) 213^218214
2.4. Induction and analysis of apoptosis
HeLa cells were seeded in 6-well plates (1.5U105 cells/well) 24 h
before transfection with increasing amounts of plasmids using the
calcium phosphate technique. After 36 h, the cells received new me-
dium containing either 15 Wg/ml cycloheximide (CHX) or 15 Wg/ml
CHX plus 2.5 ng/ml tumor necrosis factor (TNF) or no additives for
the control cultures. After 7 h, the percentage of apoptotic cells was
determined under microscopic observation in 10 randomly selected
¢elds as recently detailed [15]. Brie£y, percent apoptosis was calcu-
lated by dividing the number of cells with apoptotic morphology (ex-
hibiting membrane blebbing and/or cell body condensation) by the
total number of cells. In control experiments, Hoechst staining had
indicated that cells scored as apoptotic by morphology also exhibited
nuclear condensation and fragmentation. Caspase 3 and caspase 8
activities were evaluated using the ApoAlert1 (Clontech) £uorescent
assay kits as described [15].
2.5. Protein extraction and immunoblot analyses
Protein extracts were prepared as described [13]. For HSV R1 and
HuR1 detection, 168R1, a rabbit polyclonal anti-HSV-2 R1 antise-
rum, and a monoclonal antibody speci¢c for HuR1 kindly provided
by Mike Cordingley were used, respectively. Quanti¢cation of the
percent recombinant protein in total protein extracts was done by
immunoblotting using as standards puri¢ed HSV-2 R1 or extracts
of 293 cells overexpressing HuR1.
3. Results
3.1. HSV R1 possesses a domain with similarity with the
K-crystallin domain of sHsps
Recently, a protein, ¢rst described as having homology with
the amino-terminal domain of the HSV-2 R1 [16], was later
demonstrated to be a member of the sHsp family and named
HspB8 [17]. These observations prompted us to scrutinize R1
for the presence of an K-crystallin domain. A Clustal W align-
ment of the K-crystallin domains of nine human sHsps was
used to generate a pro¢le that was compared with the HSV-1
and HSV-2 R1 sequences. The best similarity detected spans
from amino acids 300 to 400. The alignment presented in Fig.
1A, which results from improvement by manual editing,
shows that many consensus residues are conserved in the R1
sequences. Noteworthy are four residues (indicated by trian-
gles): L325, R354, G380 and L382 in HSV-2 R1. The Leu
residue corresponding to L325, when changed by even a rel-
atively conservative Ala mutation in Synechocystis Hsp16.6,
caused severe loss of Hsp16.6 function in vivo [22]. The R354
residue corresponds to a mutation site in two human genetic
disorders: the R116C mutation in KA-crystallin and the
R120G mutation in KB-crystallin respectively cause autoso-
mal dominant cataract [30] and desmin-related myopathy
[31]. The G380 and L382 residues present in the HSV-2 R1
hydrophobic motif, GLLNY, are the most conserved amino
acids among all known sHsps [20,32]. However, some other
consensus residues are not conserved in the R1 sequences
explaining why the R1 K-crystallin domain is not detected
by standard pro¢les such as the ‘heat shock hsp20 protein
family pro¢le’ of Prosite. These replacements could result
from constraints imposed by the presence on one side of the
unique NH2 domain exhibiting a low level of similarity be-
tween the two HSV R1s (6 50%) and on the other side of the
large highly homologous RR domain (Fig. 1B).
3.2. HSV-2 R1 forms high molecular weight complexes
The K-crystallin domain in HSV-2 R1 suggested a chaper-
one function. As the chaperone activity of sHsps is often
related to their capacity to oligomerize [18,22], we ¢rst deter-
mined the molecular mass of HSV-2 R1 by gel ¢ltration on a
Superdex 200 column in physiological salt conditions without
adding any nucleotide. For an R1 concentration of 0.7 WM,
we observed with either unlabeled R1 detected by optical den-
sity (data not shown) or 32P-labeled R1 (Fig. 2A) a major
broad peak corresponding to molecular masses v 750 kDa,
the value expected for an R1 hexamer, and a minor one at
V250 kDa, the value expected for an R1 dimer. At a ¢ve-fold
higher R1 concentration, the peak corresponding to the dimer
disappeared, indicating that the formation of multimers is de-
pendent on the concentration of the protein (Fig. 2B). Adding
1 M NaCl to the protein and the eluent produced a drastic
shift of the peak to a position slightly higher than for the
dimer (Fig. 2B), suggesting that oligomerization involved
complementary ionic charges.
3.3. HSV-2 R1 suppresses the thermal aggregation of CS
We next investigated the HSV-2 R1 chaperone activity by
measuring the e¡ect of adding it in increasing concentrations
on the kinetics of denaturation of CS at 43‡C. The K-crystal-
lin domain containing protein Hsp27 and an inactive mutant
of Hsp27, v5^23Hsp27, were used as positive and negative
controls, respectively. At concentrations higher than 4 Wg/
Fig. 2. Gel ¢ltration chromatography shows that HSV-2 R1 forms
hexameric structure. A: Puri¢ed 32P-labeled HSV-2 R1 (0.7 WM)
was loaded on a Superdex 200 column and radioactivity in each
fraction was measured. B: HSV-2 R1 (3.5 WM) was loaded in stan-
dard bu¡er (Control) or in the presence of 1 M NaCl (NaCl) and
the absorbance at 280 nm was recorded. The elution volume of pro-
tein standards and blue dextran (V0) are shown above.
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ml, HSV-2 R1 totally inhibited the denaturation and aggre-
gation of CS at 43‡C as measured from the light scattering of
the CS solution (Fig. 3A) or the amount of CS pelletable at
17 000Ug after 30 min of heating (data not shown). The IC50
(the concentration required to inhibit 50% of CS denatura-
tion) value was 1.1 Wg/ml for HSV-2 R1 as compared to
3.2 Wg/ml for Hsp27. v5^23Hsp27 had no e¡ect at concentra-
tions up to 25 Wg/ml (Fig. 3B). Considering that at the low
e¡ective concentration of HSV-2 R1 it was present as a mix-
ture of hexamer and dimer with masses between 750 kDa and
250 kDa whereas Hsp27 forms a 24-mer of 600 kDa, it can be
estimated that R1 (IC50 = 1.5^4.5 nM) has a chaperone activ-
ity as good as if not better than Hsp27 (IC50 = 5.3 nM).
3.4. Cellular R1 does not protect against apoptosis and does not
possess chaperone activity
Attempts to determine the functional importance of the
HSV R1 K-crystallin domain in the HSV-2 R1 anti-apoptotic
activity by deleting it completely or in part have been ham-
pered by obtaining either pro-apoptotic proteins such as
R1(v2^357) [13] or fully insoluble products such as R1(v2^
398), R1(v2^496), R1(v378^445) and R1(v107^446) (unpub-
lished data). Thus, to get a ¢rst insight into the importance of
the K-crystallin domain in both anti-apoptotic and chaperone
activities of HSV R1, we asked whether mammalian R1, an
R1 without an K-crystallin domain, would exhibit such activ-
ities. To study the anti-apoptotic activity, HeLa cells were
transfected with plasmids expressing either the HSV-2 R1 or
HuR1 and the extent of apoptosis was measured by micro-
scopic observation (Fig. 4A) and determination of caspase 3
and caspase 8 activities (Fig. 4B). Whereas the HSV-2 R1
e⁄ciently protected cells against apoptosis induced by
TNF+CHX as previously observed [15], HuR1 was not pro-
tective at all. Protein quanti¢cation performed using appro-
priate standards for the samples transfected with 50 Wg/ml of
plasmids showed that both R1 proteins were produced in
roughly similar amounts (Fig. 4C).
The ability of puri¢ed mR1 to suppress the thermal aggre-
gation of CS was studied in the conditions used to demon-
strate the chaperone activity of HSV-2 R1 (Fig. 3C). These
experiments showed that mR1 (13.5 Wg/ml) not only did not
impair the aggregation of CS but also that it was self-aggre-
gating when heated at 43‡C. Similar results were obtained in
Fig. 3. HSV-2 R1 but not mammalian R1 suppresses the thermal aggregation of CS. A: Kinetics of denaturation of CS. Solutions containing
CS alone (b), HSV-2 R1 (9.4 Wg/ml)+CS (F), Hsp27 (14.2 Wg/ml)+CS (a) or v5^23Hsp27 (12.4 Wg/ml)+CS (E) were heated at 43‡C for up to
30 min. Light scattering at 320 nm is indicated in relative arbitrary units. B: Dose-dependent protection of denaturation as shown by the rela-
tive light scattering at 30 min as a function of the concentration of the chaperones. Symbols are as in A. C: Kinetics of denaturation of CS.
Solutions containing CS alone (b), mR1 (13.5 Wg/ml)+CS (F) or mR1 alone (R) were processed as described in A. D: The experiment de-
scribed in C was repeated in the presence of 4 mM ATP plus 10 mM MgCl2.
Fig. 4. HuR1 does not protect against apoptosis. HeLa cells were
transfected with increasing amounts of the plasmids pAdCMV5-
HSV-2R1 (F, E) or pAdCMV5-HuR1 (b, a). After 36 h, CHX (E,
a) or CHX+TNF (F, b) were added for 7 h. A: The percent apo-
ptotic cells was evaluated under microscopic observation. Values
represent the means of 10 randomly selected ¢elds. B: Caspase 3
(solid lines) and caspase 8 (dashed lines) activities are expressed in
pmol/min/mg. C: The amounts of HSV-2 R1 and HuR1 accumu-
lated in cells transfected with 50 Wg/ml of plasmid were evaluated
with an immunoblot analysis by comparison with standards.
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the presence of 4 mM ATP plus MgCl2 (Fig. 3D). These R1
ligands are necessary for mammalian RR activity [33] and it
has been shown that at these concentrations they cause R1
oligomerization [2,3]. These data showed that mammalian R1,
an R1 without an K-crystallin domain, has neither chaperone
nor anti-apoptotic activity.
4. Discussion
Here, we have shown that the HSV-2 R1, which contains a
domain exhibiting similarity to the K-crystallin domain of
sHsps, has a chaperone activity similar to Hsp27, a sHsp.
To our knowledge, HSV R1 is the ¢rst protein produced by
human cells identi¢ed as containing one K-crystallin domain
followed by another functional domain, herein a RR domain.
Only plant proteins have been reported to contain an K-crys-
tallin domain at variable positions in their polypeptide chains.
For none of these plant proteins, which are unrelated to
sHsps, has a function been ascribed to this structural motif
[20]. Interestingly, for some of the proteins containing p23-like
domains such as B5+B5R £avo-hemo cytochrome NAD(P)H
oxidoreductase, this motif is present as a hinge between the
cytochrome and the reductase domains. From what is known
about the function of the p23-like domain in the di¡erent
protein families in which it is present, it was postulated that
the p23 domain is involved in stabilizing folding structure
and/or in mediating protein^protein interaction [25].
The position of the K-crystallin domain in HSV R1, where
it replaces the allosteric regulatory site able to bind ATP or
dATP present in non-viral R1 (Fig. 1B), suggests that it could
be important for multimerization that occurs in the absence of
nucleotide. mR1, which is devoid of an K-crystallin domain,
sediments mainly as a monomer in the absence of nucleotide
[2^4], and requires ATP concentrations above 1 mM to form
hexamers [3]. By comparison with what is known for sHsps
and p23 domain-containing proteins, we propose as a model
for HSV R1 that the K-crystallin domain could contribute to
the protein quaternary structure by providing additional
point(s) of interaction between the two monomers, thus sta-
bilizing the dimer. Additionally or alternatively the domain
could provide point(s) of contact essential for multimeriza-
tion. Our observation that the HSV-2 R1 forms a multimeric
structure at relatively low concentration in the absence of any
added nucleotide is in favor of this model.
The chaperone mechanism of sHsp appears to involve tem-
perature-regulated exposure of hydrophobic binding sites
present mainly in their K-crystallin domains [18,19]. As we
have shown that the HSV R1 but not mR1 exhibited chaper-
one activity, it can be suggested that the presence of the
K-crystallin domain is important for the chaperone activity.
In addition, K-crystallin domains are thought to play an im-
portant role in preventing sHsp self-aggregation during heat
stress [18]. Hence, we have observed that HSV R1 did not
aggregate during heating at 43‡C whereas mR1 readily formed
insoluble precipitate. Also noteworthy is the observation that
the RR activity of HSV R1 is far more resistant to heat in-
activation than that of mammalian R1, a 20 min heat treat-
ment at 50‡C inactivating only 10% of the former and more
than 99% of the latter [34]. Direct evidence for the importance
of the K-crystallin domain in the newly discovered HSV R1
activities has so far proven di⁄cult to obtain because partial
or total deletion of the domain alters the solubility of the
protein. More speci¢c mutations such as substitution of con-
served residues R354 and L382 could be helpful as similar
substitutions in sHsp have been shown to reduce their chap-
erone activity [35,36]. The deleterious e¡ect of deleting the
K-crystallin domain on R1 protein solubility suggests that
this domain could also play an important role in the polypep-
tide folding.
Since viruses are obligate intracellular parasites, the folding
of viral proteins is generally accommodated by host chaper-
ones that are often induced upon viral infection. An increas-
ing number of viruses have been described to encode chaper-
ones of diverse families including homologues of Hsp70, DnaJ
and GroES [37]. However, HSV is the ¢rst virus described to
encode a protein having a structural domain and chaperone
activity similar to sHsp. The importance of this new function
of HSV R1 in viral pathogenesis remains to be studied. One
possibility is the protection of viral polypeptides during HSV
reactivation triggered by fever. Thus, by assisting cellular
chaperones in protecting viral proteins during heat stress,
HSV R1 could contribute to the e⁄ciency of virus production.
In favor of that are observations made with the HSV-1 R1
null mutant ICP6v. When tested in exponentially growing
Vero cells where the cellular RR complemented the defect in
viral reductase, this mutant grew as well as the wild type at
33‡C. In contrast, at 39.5‡C the growth of the mutant was
severely compromised whereas that of the wild type was only
slightly a¡ected [38]. Another possibility is that even at 37‡C
HSV R1, which accumulates at a high level (2% of total pro-
teins), could be necessary to prevent protein aggregation dur-
ing the high rate of viral protein synthesis.
In summary, the anti-apoptotic HSV-2 R1, which possesses
a domain distantly related to the K-crystallin domain of
sHsps, has also a chaperone activity similar to that of sHsps.
In contrast, without an K-crystallin domain mammalian R1
does not have chaperone activity. As we have also observed
that HuR1 could not impair apoptosis induced by death re-
ceptor activation, it is tempting to speculate that the K-crys-
tallin domain is important for the HSV R1 anti-apoptotic
activity. It could act either directly via its role for chaperone
activity or oligomer formation or indirectly by being necessary
for an e⁄cient folding of the protein. Formation of large
oligomers involving the K-crystallin domain has been shown
to be important for the anti-apoptotic activity of some sHsps
[39,40].
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